Similar Articles
Association of Plasma Homocysteine Level and Carotid Intima-Media Thickness in Rheumatoid Arthritis Patients Receiving Methotrexate
Emrullah HAYTA, Sami HİZMETLİ, Mehmet Haydar ATALAR, Ziynet ÇINAR
DOI: 10.5606/ArchRheumatol.2015.4249
A Rapidly Progressive Variant of Psoriatic Arthritis: Psoriatic Onycho-Pachydermo-Periostitis
Sibel SÜZEN ÖZBAYRAK, Vildan BİNAY SAFER, Mustafa ÖZBAYRAK
DOI: 10.5606/ArchRheumatol.2016.5682
Sensorineural Hearing Impairment and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients Without Traditional Cardiovascular Risk Factors
Hector MACIAS-REYES, Sergio DURAN-BARRAGAN, Cynthia R. CARDENAS-CONTRERAS, Cesar G. CHAVEZ-MARTIN, Eduardo GOMEZ-BAÑUELOS, Rosa E. NAVARRO-HERNANDEZ, Carlos O. YANOWSKY-GONZALEZ, Laura GONZALEZ-LOPEZ, Jorge I. GAMEZ-NAVA, Monica VAZQUEZ-DEL MERCADO
DOI: 10.5606/ArchRheumatol.2016.5739
Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients with Psoriatic Arthritis
Berna TANDER, Yasemin ULUS, Yüksel TERZİ, Yeliz ZAHİROĞLU, Hakan KESMEN, Bayram FARİSOĞULLARI, Yeşim AKYOL, Ayhan BİLGİCİ, Ömer KURU
DOI: 10.5606/ArchRheumatol.2016.5741
Development of Atherosclerotic Cardiovascular Mortality in Gouty Arthritis and Rheumatoid Arthritis Patients: Are They Associated With Mean Platelet Volume and Neutrophil-Lymphocyte Ratio? A Comparative Study
Muhammet MADEN, Gülsüm Emel PAMUK, Ömer Nuri PAMUK
DOI: 10.5606/ArchRheumatol.2017.6033
Management of Psoriatic Arthritis: Turkish League Against Rheumatism (TLAR) Expert Opinions
Kemal NAS, Erkan KILIÇ, Remzi ÇEVİK, Hatice BODUR, Şebnem ATAMAN, Figen AYHAN, Özgür AKGÜL, Ayşen AKINCI, Zuhal ALTAY, Erhan Çapkın, Abdullah Zübeyir DAĞLI, Tuncay DURUÖZ, Gülcan GÜRER, Feride GÖĞÜŞ, Yeşim GARİP, Cahit KAÇAR, Ayhan KAMANLI, Ece KAPTANOĞLU, Taciser KAYA, Hilal KOCABAŞ, Erhan Ali ÖZDEMİREL, Sumru ÖZEL, İlhan SEZER, İsmihan SUNAR, Gürkan YILMAZ
DOI: 10.5606/ArchRheumatol.2018.6946
Neuropathic Pain: Unexplored and Significant Relationship With Psoriatic Arthritis and Functional Parameters
Çağrı Ünal ULUTATAR, Fırat ULUTATAR, Mehmet Tuncay DURUÖZ
DOI: 10.46497/ArchRheumatol.2020.7215
Coexistence of Juvenile Systemic Lupus Erythematosus and Juvenile Spondyloarthropathy: A Case Report and Review of the Literature
Ayşe TANATAR, Ummihan TOPAL, Şerife GÜL KARADAĞ, Hafize Emine SÖNMEZ, Nuray AKTAY AYAZ
DOI: 10.5606/ArchRheumatol.2020.7468
Biomarkers of Cardiovascular Disease in Patients With Ankylosing Spondylitis
Ümit SARP, Evren ÜSTÜNER, Sehim KUTLAY, Şebnem ATAMAN, Sim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7868
Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs
Yaşar KESKİN, Kemal NAS, Erkan KILIÇ, Betul SARGIN, Sevtap ACER KASMAN, Hakan ALKAN, Nilay ŞAHİN, Gizem CENGİZ, Nihan CUZDAN, İlknur ALBAYRAK GEZER, Dilek KESKİN, Cevriye MÜLKOĞLU, Hatice RESORLU, Şebnem ATAMAN, Ajda BAL, Mehmet Tuncay DURUOZ, Okan KÜÇÜKAKKAS, Ozan Volkan YURDAKUL, Meltem ALKAN MELİKOĞLU, Yıldıray AYDIN, F. Figen AYHAN, Hatice BODUR, Mustafa ÇALIŞ, Erhan ÇAPKIN, Gül DEVRİMSEL, Kevser GÖK, Sami HİZMETLİ, Ayhan KAMANLI, Hilal ECESOY, Öznur KUTLUK, Nesrin ŞEN, Ömer Faruk ŞENDUR, İbrahim TEKEOĞLU, Sena TOLU, Murat TOPRAK, Tiraje TUNCER
DOI: 10.46497/ArchRheumatol.2021.7874
Knowledge of cardiovascular disease risk in rheumatoid arthritis patients before and after educational intervention from a Southeast Asia country: Malaysia
Boon Ching TEOH, Syed Azhar SYED SULAIMAN, Bee Eng TAN
DOI: 10.46497/ArchRheumatol.2021.7726
Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus
Mehmet Ali BALCI, Engin ATLI, Hakan GüRKAN
DOI: 10.46497/ArchRheumatol.2021.8024
Evaluation of musculoskeletal adverse effects in patients on systemic isotretinoin treatment: A cross-sectional study
Emine Müge Acar, Senem Şaş, Fatmanur Aybala Koçak
DOI: 10.46497/ArchRheumatol.2022.8645
Lipoprotein-associated phospholipase A2 and carotid intima-media thickness in primary Sjögren syndrome
Selcan Gültuna, Sevinç Can Sandıkçı, Hatice Kaplanoğlu, Fevzi Nuri Aydın, Funda Seher Özalp Ateş
DOI: 10.46497/ArchRheumatol.2022.8838
Serum progranulin levels in axial spondyloarthropathy and relationship with clinical features
Didem İldemir Doğangün, Meliha Kasapoğlu Aksoy, Lale Altan
DOI: 10.46497/ArchRheumatol.2022.8542
Validity and reliability of the Turkish version of Psoriasis Epidemiology Screening Tool for the detection of psoriatic arthritis in patients with psoriasis
Serdar Kaymaz, Uğur Karasu, Nida Kaçar, Hakan Alkan
DOI: 10.46497/ArchRheumatol.2022.8221
The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec
DOI: 10.46497/ArchRheumatol.2022.9255
Proprotein convertase subtilisin/kexin 9 (PCSK9) in patients with diffuse systemic sclerosis: A marker of disease activity and severe disease manifestations with potential therapeutic implementations
Joy Artin, Yumn A. Elsabagh, Laila Rashed, Mohamed A. Hussein
DOI: 10.46497/ArchRheumatol.2023.9638
Examining the functions of the vascular endothelial growth factor/hypoxia-inducible factor signaling pathway in psoriatic arthritis
Yavuz Kiliç, Derya Guzel Erdogan, Merve Baykul, Kemal Nas
DOI: 10.46497/ArchRheumatol.2023.9898
Secukinumab after first-line tumor necrosis factor-alpha inhibitor therapy in psoriatic arthritis: A real-world retrospective cohort study
Tumay Ak, Leyla Mustafayeva, Ali Yagiz Ayla, Yeliz Celik, Gunay Can, Serdal Ugurlu
DOI: 10.46497/ArchRheumatol.2024.10050